These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2726625)

  • 1. Estrogen replacement therapy and vascular disease: the Leisure World Study.
    Paganini-Hill A
    Postgrad Med; 1989 Apr; Spec No():49-50; discussion 89-90. PubMed ID: 2726625
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
    Wilson PW
    Postgrad Med; 1989 Apr; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular diseases and hormone replacement therapy in females].
    Szücs J
    Orv Hetil; 1995 Feb; 136(8 Suppl 1):455-7. PubMed ID: 7877817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy.
    Judd HL; Cleary RE; Creasman WT; Figge DC; Kase N; Rosenwaks Z; Tagatz GE
    Obstet Gynecol; 1981 Sep; 58(3):267-75. PubMed ID: 7022279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of estrogen replacement therapy].
    Tikkanen MJ
    Duodecim; 1996; 112(12):1089-95. PubMed ID: 10593010
    [No Abstract]   [Full Text] [Related]  

  • 8. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular accidents of estrogen therapy for prostatic cancer metastases].
    Jurascheck F
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):400-2. PubMed ID: 4804405
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy at menopause. How benefits outweigh risks.
    Griffing GT; Allen SH
    Postgrad Med; 1994 Oct; 96(5):131-40. PubMed ID: 7937412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone replacement therapy of menopause in women with vascular risk factors].
    Charbonnel B
    Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
    Fidel J; Nelken L
    Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen and cardiovascular disease.
    Keresztes PA; Dan AJ
    Cardiovasc Nurs; 1992; 28(1):1-6. PubMed ID: 1728960
    [No Abstract]   [Full Text] [Related]  

  • 17. [Menopause in women--hormonal replacement therapy].
    Kulikowski M; Tomaszewska I
    Pol Tyg Lek; 1995 Nov; 50(44-47):5-9. PubMed ID: 8643429
    [No Abstract]   [Full Text] [Related]  

  • 18. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
    Clarkson TB; Karas RH
    Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.